Ketamine for Obsessive-Compulsive Disorder

Ketamine in OCD: Efficacy and Effects on Stress and Cognition

Recruiting N/A Interventional Study
Obsessive-Compulsive Disorder Psychiatric Disorder
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Medical University of Vienna · Other
Who this trial is looking for

This trial is looking for people with obsessive-compulsive disorder (OCD) who have tried at least one treatment before. Participants will receive low-dose ketamine to see if it helps improve their OCD symptoms.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with obsessive-compulsive disorder.
  • I have a score of 16 or higher on the Yale-Brown Obsessive Compulsive Scale.
  • I am able to give written informed consent.
  • I have tried at least one treatment for OCD.

You may not be able to join if

  • I have a history of current or past psychotic disorder.
  • I had a manic episode within the last three years.
  • I have current or unstable remitted substance abuse except nicotine.
  • I am pregnant or could become pregnant and do not use contraception.
  • I have any current severe personality disorder except anankastic personality disorder.
  • I have unstable suicidality.
  • I have unstable hypertension.
  • I have untreated hyperthyroidism.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main goal of this trial is to demonstrate therapeutic efficacy of low dose ketamine in patients with OCD. We expect that ketamine will alleviate symptoms in the hours following application, but also - if effective - that the anti-OCD effects might last for several days after a single infusion.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Primary diagnosis of obsessive-compulsive disorder * A score of 16 or higher on the Yale-Brown Obsessive Compulsive Scale and ability to provide written informed consent * At least one previous treatment for OCD Exclusion Criteria Experimental Group: * Any history of current…
Contacts

Christoph Kraus, MD PhD

+4314040035680

christoph.kraus@muv.ac.at

CONTACT